Leviathan Announces Acquisition of Cannabis Technology Company

Toronto, Ontario–(Newsfile Corp. – June 9, 2022) – Leviathan Natural Products Inc. (CSE: EPIC) (OTCQB: LVCNF) (the “Company” or “Leviathan”) makes the following announcements:


Leviathan announces that it has completed the acquisition of One Cannabis Market Inc. (“OCM”). OCM is a privately held technology company that provides solutions for consumers and businesses in dynamic markets. The company’s mission is to lead the cannabis technology industry through innovation and value creation.


Leviathan acquired 100% of the issued and outstanding shares of OCM in exchange for 500,000 common shares of Leviathan (the “Issued Shares”) pursuant to a share purchase agreement dated June 9, 2022. The issued shares will be subject to resale restrictions. or transfer as may be required by applicable securities laws from time to time, including without limitation under National Instrument 45-102 – Resale Restrictions.

As part of the closing of the transaction, OCM Founder and Chairman Kamyar Hosseini (“Kam”) will join Leviathan as Chief Technology Officer and help grow Leviathan’s technology business. As part of Kam’s appointment, Leviathan’s Board of Directors authorized the issuance of 500,000 Leviathan stock options to Kam, exercisable at C$1.10 per share and vesting over 2 years .


One Cannabis Market Inc, is a technology company that provides solutions to consumers and businesses in dynamic markets. OCM’s technology addresses the challenges faced by consumers seeking information in saturated markets and businesses seeking single-source software.


The press release issued on June 3, 2022 (the “June 3 Press Release”) incorrectly stated that there were a total of 8,700,000 stock options representing approximately 8% of the outstanding common shares of the society. The June 3 press release should have indicated that there were, as of that date, a total of 8,662,500 stock options representing approximately 9% of the Company’s outstanding common shares.

As of the date of this press release, Leviathan has a total of 3,825,000 stock options representing approximately 4% of the Company’s outstanding common shares.

About Leviathan Natural Products Inc.

Leviathan primarily focuses on non-psychoactive hemp-derived products for the health and wellness market. Leviathan plans to execute a series of buy and build transactions spanning all vertical markets in Canada and internationally. The company’s global capabilities position it to become a leading multi-jurisdictional cannabinoid producer – a producer that brings together the best cannabinoid products, brands and expertise from Canada and around the world. The Leviathan portfolio currently includes Jekyll+Hyde Brand Builders Inc., a marketing services agency specializing in the cannabis/hemp industry; Leviathan US, Inc., which manufactures cannabidiol products from its factory in Carthage, Tennessee; LCG Holdings Inc., a planned cannabis and hemp cultivation and processing facility in Carmen de Viboral, Colombia; and Woodstock Biomed Inc., which owns a 30-acre property with greenhouse infrastructure in Pelham, Ontario. The Woodstock property is operated under a lease agreement with Medical Saints Ltd., a licensed industrial hemp producer regulated by Health Canada. The agreement enables significant research and development (“R&D”) activities in the industrial hemp sector.

For more information please contact

Tanvi Bhandari
Chief executive officer
Leviathan Natural Products Inc.
Tel: 717-888-8889

[email protected]




Certain information contained in this press release constitutes forward-looking statements under applicable securities laws. All statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend” or negatives of these terms. and similar expressions.

Forward-looking statements are based on certain assumptions, including successful application to be a Licensed Cannabis Producer and Seller, expected growth, results of operations, performance, industry trends and growth opportunities. Although Leviathan considers these assumptions to be reasonable, based on currently available information, they are inherently subject to significant business, economic and competitive uncertainties and contingencies and may prove to be incorrect. Readers are cautioned not to place undue reliance on forward-looking statements.

Forward-looking statements also necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions, adverse industry events, marketing costs, loss of markets, legislative developments and future regulatory issues, the inability to access sufficient capital on favorable terms, the medical and recreational cannabis industry in Canada generally, income tax and regulatory matters, Leviathan’s ability to perform its business strategies, competition, crop failure, currency and interest rate fluctuations and other risks.

Readers are cautioned that the foregoing is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. Such information, although considered reasonable by management when prepared, may prove to be incorrect and actual results may differ from those anticipated. Forward-looking statements are not guarantees of future performance. Except as required by law, Leviathan disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, events or otherwise. The forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Source: Leviathan Natural Products Inc.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/127085

Comments are closed.